The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(N-((3S,3aR,6R,6aS)-6-(benzyloxy)hexahydrofuro[3,2-b]furan-3-yl)-2-(4-methoxyphenyl)acetamido)-N-cyclohexyl-2-methylpropanamide ID: ALA3963267
PubChem CID: 134151146
Max Phase: Preclinical
Molecular Formula: C32H42N2O6
Molecular Weight: 550.70
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(CC(=O)N([C@H]2CO[C@H]3[C@@H]2OC[C@H]3OCc2ccccc2)C(C)(C)C(=O)NC2CCCCC2)cc1
Standard InChI: InChI=1S/C32H42N2O6/c1-32(2,31(36)33-24-12-8-5-9-13-24)34(28(35)18-22-14-16-25(37-3)17-15-22)26-20-39-30-27(21-40-29(26)30)38-19-23-10-6-4-7-11-23/h4,6-7,10-11,14-17,24,26-27,29-30H,5,8-9,12-13,18-21H2,1-3H3,(H,33,36)/t26-,27+,29+,30+/m0/s1
Standard InChI Key: YIKINYJURYSMCU-UGWFNHDDSA-N
Molfile:
RDKit 2D
42 46 0 0 0 0 0 0 0 0999 V2000
15.7289 -11.9359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5184 -12.7325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3140 -12.5186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8460 -12.0284 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.7794 -10.7025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3356 -11.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5748 -10.9169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6137 -11.7374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4063 -11.9527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8588 -11.2651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3433 -10.6276 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.6075 -12.5550 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
13.5703 -10.0952 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
14.6998 -12.7207 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1782 -13.3578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9171 -13.4539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4675 -14.1263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3676 -13.2262 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0440 -14.8263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7383 -13.4682 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4962 -14.1584 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.1386 -14.1871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7102 -14.8885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1070 -15.6052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9284 -15.6237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3516 -14.9194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9573 -14.1964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4873 -9.9348 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6660 -9.9308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2568 -9.2169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6764 -8.5087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2678 -7.7954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4457 -7.7909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0337 -8.5057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4405 -9.2161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2287 -14.8045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8049 -15.5040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1995 -16.2222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0222 -16.2366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4422 -15.5365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7796 -16.9191 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.1744 -17.6346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 8 1 0
7 5 1 0
5 6 1 0
6 4 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 7 1 0
8 12 1 6
7 13 1 6
9 14 1 6
14 15 1 0
14 2 1 0
2 16 1 0
15 17 1 0
15 18 2 0
17 19 1 0
16 20 1 0
16 21 2 0
20 22 1 0
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
5 28 1 1
28 29 1 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
19 36 2 0
36 37 1 0
37 38 2 0
38 39 1 0
39 40 2 0
40 19 1 0
41 42 1 0
38 41 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 550.70Molecular Weight (Monoisotopic): 550.3043AlogP: 4.05#Rotatable Bonds: 10Polar Surface Area: 86.33Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.27CX LogD: 4.27Aromatic Rings: 2Heavy Atoms: 40QED Weighted: 0.48Np Likeness Score: -0.24
References 1. Barros TG, Santos JAN, de Souza BEG, Sodero ACR, de Souza AMT, da Silva DP, Rodrigues CR, Pinheiro S, Dias LRS, Abrahim-Vieira B, Puzer L, Muri EMF.. (2017) Discovery of a new isomannide-based peptidomimetic synthetized by Ugi multicomponent reaction as human tissue kallikrein 1 inhibitor., 27 (2): [PMID:27914800 ] [10.1016/j.bmcl.2016.11.051 ]